Top

Current Treatment Options in Gastroenterology

Content (10 Articles)

Immunomodulator therapy in inflammatory bowel disease

Peter E. Legnani, Asher Kornbluth

Nutritional treatments in inflammatory bowel disease

Maria O’Sullivan, Colm O’Morain

Surgical management of inflammatory bowel disease

Robert R. Cima, John H. Pemberton

Extraintestinal complications of inflammatory bowel disease

Ad A. van Bodegraven, Ben A. C. Dijkmans, Paul Lips, Tom J. Stoof, A. Salvador Peña, Stephan G. M. Meuwissen

Inflammatory bowel disease during pregnancy

Ramona Rajapakse, Burton I. Korelitz

Refractory inflammatory bowel disease

Thomas A. Judge, Gary R. Lichtenstein

Anal carcinoma

Eric J. Szilagy, Asim Farid

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.